Rosalind Advisors Inc. Invests $1.49 Million in Alpha Cognition, Inc. (NASDAQ:ACOG)

Rosalind Advisors Inc. bought a new stake in Alpha Cognition, Inc. (NASDAQ:ACOG) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 252,753 shares of the company’s stock, valued at approximately $1,489,000. Alpha Cognition accounts for approximately 0.7% of Rosalind Advisors Inc.’s holdings, making the stock its 22nd largest position. Rosalind Advisors Inc. owned about 1.58% of Alpha Cognition at the end of the most recent reporting period.

Alpha Cognition Price Performance

ACOG opened at $5.37 on Friday. The firm has a market capitalization of $86.03 million, a P/E ratio of -2.10 and a beta of 2.50. The business’s fifty day simple moving average is $5.90. Alpha Cognition, Inc. has a fifty-two week low of $4.66 and a fifty-two week high of $7.00.

Analyst Ratings Changes

Separately, HC Wainwright initiated coverage on Alpha Cognition in a research report on Tuesday. They issued a “buy” rating and a $20.00 price objective for the company.

Alpha Cognition Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.